Study of Enbrel (Etanercept) for the Treatment Sub-Acute Pulmonary Dysfunction After Allogeneic Stem Cell Transplant
Status:
Completed
Trial end date:
2009-02-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the effectiveness of etanercept in the treatment of
patients with sub-acute lung injury following a bone marrow transplant. This study will also
examine the toxicity of treatment with etanercept as well as whether there is an improved
quality of life in these patients.
Phase:
Phase 2
Details
Lead Sponsor:
University of Michigan Cancer Center University of Michigan Rogel Cancer Center